Author:
Yamauchi Takahiro,Uzui Kanako,Nishi Rie,Shigemi Hiroko,Ueda Takanori
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference36 articles.
1. Faderl S, Gandhi V, Kantarjian H, Plunkett W: New nucleoside analogues in clinical development. Cancer Chemother Biol Response Modif. 2002, 20: 37-58.
2. Liu X, Kantarjian H, Plunkett W: Sapacitabine for cancer. Expert Opin Investig Drugs. 2012, 21: 541-555.
3. Ghanem H, Kantarjian H, Ohanian M, Jabbour E: The role of clofarabine in acute myeloid leukemia. Leuk Lymphoma. 2013, 54: 688-698.
4. Cohen MH, Johnson JR, Massie T, Sridhara R, McGuinn WD, Abraham S, Booth BP, Goheer MA, Morse D, Chen XH, Chidambaram N, Kenna L, Gobburu JV, Justice R, Pazdur R: Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma. Clin Cancer Res. 2006, 12: 5329-5335.
5. Gandhi V, Plunkett W: Clofarabine and nelarabine: two new purine nucleoside analogs. Curr Opin Oncol. 2006, 18: 584-590.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献